Visualitza per matèria "In silico toxicity"

Ordena per: Ordre: Resultats:

  • Cases, Montserrat; Briggs, Katharine; Steger-Hartmann, Thomas; Pognan, François; Marc, Philippe; Kleinöder, Thomas; Schwab, Christof H.; Pastor Maeso, Manuel; Wichard, Jörg; Sanz, Ferran (MDPI, 2014)
    The high-quality in vivo preclinical safety data produced by the pharmaceutical industry during drug development, which follows numerous strict guidelines, are mostly not available in the public domain. These safety data ...
  • Briggs, Katharine; Cases, Montserrat; Heard, David J.; Pastor Maeso, Manuel; Pognan, François; Sanz, Ferran; Schwab, Christof H.; Steger-Hartmann, Thomas; Sutter, Andreas; Watson, David K.; Wichard, Jörg (MDPI, 2012)
    There is a widespread awareness that the wealth of preclinical toxicity data that the pharmaceutical industry has generated in recent decades is not exploited as efficiently as it could be. Enhanced data availability for ...

Cerca

Visualitza

El meu compte

Amb col·laboració de Complim Participem